British Pharmacopoeia 2026 Edition

Product Description

New, legally enforced standards available from 1 August 2025. The BP 2026 edition supersedes the BP 2025 and becomes legally effective on 1 January 2026.

Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

It includes approximately 4,000 monographs, which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and internationally.

New for the BP 2026 edition

• 19 new BP monographs and 34 new monographs reproduced from the 11th edition of the Ph. Eur., as amended by supplements 11.6 to 11.8

• two new appendices, four supplementary chapters, and six new infrared reference

spectra have been added to the collection

• 12 new BPCRS have been produced and referenced

• 131 amended BP monographs

• all monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.6 to 11.8

• the Ph. Eur. 12th edition, comprising supplements 12.1, 12.2 and 12.3, included as an in-year online and download product

Multi-user online licence = POA

Flexible annual multi-user access options are available to suit every need – from licences that allow unlimited users within one country to share access (within licence restrictions), to global licences and academic licences for wider availability. For more information on these licenses, call or email.

ISBN: 9780113231065 & 9780113231072